Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barth

Showing results (171-180 of 400) with videos related to

Pageof 40
Sort By:
American Journal of Medical Genetics|October 21, 1999
Trisomy 2p syndrome: a fetus with anencephaly and postaxial polydactylyG K Hahm, R F Barth, G M Schauer, et al.
Neurosurgery|May 1, 1996
Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruptionW Yang, R F Barth, D E Carpenter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1970
Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharideP J Baker, P W Stashak, D F Amsbaugh, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumorsL Liu, R F Barth, D M Adams, et al.
Neurosurgery|February 5, 1999
Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7)R F Barth, W Yang, R T Bartus, et al.
Molecular Cancer Therapeutics|January 25, 2006
Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugatesGong Wu, Rolf F Barth, Weilian Yang, et al.
Bioconjugate Chemistry|January 18, 2007
Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFRXiaogang Pan, Gong Wu, Weiliang Yang, et al.
Medical Oncology (Northwood, London, England)|September 20, 2025
From bench to bedside: the evolution and future of prostate-specific antigen testingIldar W Mutalip, Allyson F Barth, Garen S Sellers, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1990
Alterations in monoclonal antibody affinity and antigenic receptor site expression on mycoplasma-infected human colorectal cancer cellsO A Oredipe, R F Barth, J H Rotaru, et al.
Anticancer Research|September 1, 1996
Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumorsL Liu, R F Barth, D M Adams, et al.
Pageof 40

Showing results (171-180 of 400) with videos related to

Sort By:
Pageof 40
American Journal of Medical Genetics|October 21, 1999
Trisomy 2p syndrome: a fetus with anencephaly and postaxial polydactylyG K Hahm, R F Barth, G M Schauer, et al.
Neurosurgery|May 1, 1996
Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruptionW Yang, R F Barth, D E Carpenter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1970
Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharideP J Baker, P W Stashak, D F Amsbaugh, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumorsL Liu, R F Barth, D M Adams, et al.
Neurosurgery|February 5, 1999
Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7)R F Barth, W Yang, R T Bartus, et al.
Molecular Cancer Therapeutics|January 25, 2006
Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugatesGong Wu, Rolf F Barth, Weilian Yang, et al.
Bioconjugate Chemistry|January 18, 2007
Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFRXiaogang Pan, Gong Wu, Weiliang Yang, et al.
Medical Oncology (Northwood, London, England)|September 20, 2025
From bench to bedside: the evolution and future of prostate-specific antigen testingIldar W Mutalip, Allyson F Barth, Garen S Sellers, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1990
Alterations in monoclonal antibody affinity and antigenic receptor site expression on mycoplasma-infected human colorectal cancer cellsO A Oredipe, R F Barth, J H Rotaru, et al.
Anticancer Research|September 1, 1996
Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumorsL Liu, R F Barth, D M Adams, et al.
Pageof 40